Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05360264
What this trial is testing

TailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma Recurrent
Luca Cardone 7
Testing effectiveness (Phase 2)Study completedNCT01971034
What this trial is testing

Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.

Who this might be right for
Pancreatic Adenocarcinoma Advanced or Metastatic
Instituto do Cancer do Estado de São Paulo 41
Not applicableUnknownNCT03673423
What this trial is testing

Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Ospedale San Raffaele 138
Large-scale testing (Phase 3)UnknownNCT00088660
What this trial is testing

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

Who this might be right for
Pancreatic Cancer
Therion Biologics Corporation 250
Testing effectiveness (Phase 2)Study completedNCT00053924
What this trial is testing

Perifosine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT06850623
What this trial is testing

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
EXACT Therapeutics AS 25
Not applicableStudy completedNCT03644173
What this trial is testing

Personal Resilience Empowerment Program Study

Who this might be right for
Lung CancerCholangiocarcinomaPancreatic Cancer+1 more
Hackensack Meridian Health 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301229
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Shanghai Henlius Biotech 100
Not applicableStudy completedNCT06336694
What this trial is testing

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital, Sun Yat-Sen University 302
Large-scale testing (Phase 3)UnknownNCT00005870
What this trial is testing

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00089024
What this trial is testing

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Nebraska 29
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Early research (Phase 1)Study completedNCT01839981
What this trial is testing

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Ended earlyNCT00613730
What this trial is testing

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint

Who this might be right for
Cancer of PancreasCancer of the PancreasPancreas Cancer+1 more
Amgen 3
Not applicableLooking for participantsNCT07340151
What this trial is testing

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
The University of Texas Health Science Center at San Antonio 40
Testing effectiveness (Phase 2)Study completedNCT00016965
What this trial is testing

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)UnknownNCT05627427
What this trial is testing

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Who this might be right for
Neuroendocrine Tumor Grade 3Neuroendocrine CarcinomaPancreatic Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827953
What this trial is testing

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nelum Corp 28
Next Page